Rice University leads development of innovative bioelectronic implant for obesity and diabetes

Rice University is part of a multiuniversity research team that has secured an award of up to $34.9 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of a bioelectronic implant designed to improve adherence for obesity and type 2 diabetes (T2D) treatment while reducing development and manufacturing costs.

Palbociclib Regimen Yields ‘Incredible’ PFS Gain in Metastatic Breast Cancer

SAN ANTONIO — The addition of palbociclib (Ibrance) to current standard-of-care therapy following induction chemotherapy resulted in a significant and clinically meaningful improvement in progression-free

December 13, 2024

Opinion | Women and Children First — Or Not

Rosenbaum is a pediatrician, and a professor emeritus and special lecturer in pediatrics and medicine. Meyer is a professor of pediatrics and medical director for

October 20, 2024

European drug regulator rejects Alzheimer’s drug Leqembi, citing safety concerns

The European Medicines Agency on Friday held its ground against anti-amyloid treatments, saying it will not recommend Eisai and Biogen’s Alzheimer’s drug Leqembi for approval

July 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.